Evidence map›Paper›PMID 28592892›Full record

ArticleScientific reports2017

Noncanonical cell death program independent of caspase activation cascade and necroptotic modules is elicited by loss of TGFβ-activated kinase 1.

September R Mihaly, Yosuke Sakamachi, Jun Ninomiya-Tsuji, Sho Morioka

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Targeting RIPK1 to modulate cell death and tumour microenvironment in cancer therapy.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  3. TAK1 inhibition elicits mitochondrial ROS to block intracellular bacterial colonization.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

September R MihalyDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, 27695-7633, USA.
Yosuke SakamachiDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, 27695-7633, USA.
Jun Ninomiya-TsujiDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, 27695-7633, USA.
Sho MoriokaDepartment of Biological Sciences, North Carolina State University, Raleigh, NC, 27695-7633, USA. sm9ss@virginia.edu.ORCID 0000-0002-1153-4919

Funding

TRAINING IN BIOCHEMICAL AND ENVIRONMENTAL TOXICOLOGYT32ES007046 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Seth William Kullman · 1985 to 2026
$5.1M
TAK1 signaling network in tissue homeostasisR01GM068812 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI NINOMIYA-TSUJI, JUN · 2004 to 2013
$2.4M
TAK1 regulation of metabolismR01GM112986 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI NINOMIYA-TSUJI, JUN · 2015 to 2018
$1.4M
Role of TAB1-TAK1 signaling in tumor-associated macrophage survivalF31CA171675 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI MIHALY, SEPTEMBER R · 2013 to 2014
$64k
NCI NIH HHS F31 CA171675NIEHS NIH HHS T32 ES007046NIGMS NIH HHS R01 GM068812NIGMS NIH HHS R01 GM112986
6 · The paper itself

Abstract

Programmed cell death (PCD) occurs in several forms including apoptosis and necroptosis. Apoptosis is executed by the activation of caspases, while necroptosis is dependent on the receptor interacting protein kinase 3 (RIPK3). Precise control of cell death is crucial for tissue homeostasis. Indeed, necroptosis is triggered by caspase inhibition to ensure cell death. Here we identified a previously uncharacterized cell death pathway regulated by TAK1, which is unexpectedly provoked by inhibition of caspase activity and necroptosis cascades. Ablation of TAK1 triggers spontaneous death in macrophages. Simultaneous inhibition of caspases and RIPK3 did not completely restore cell viability. Previous studies demonstrated that loss of TAK1 in fibroblasts causes TNF-induced apoptosis and that additional inhibition of caspase leads to necroptotic cell death. However, we surprisingly found that caspase and RIPK3 inhibitions do not completely suppress cell death in Tak1-deficient cells. Mechanistically, the execution of the third cell death pathway in Tak1-deficient macrophages and fibroblasts were mediated by RIPK1-dependent rapid accumulation of reactive oxygen species (ROS). Conversely, activation of RIPK1 was sufficient to induce cell death. Therefore, loss of TAK1 elicits noncanonical cell death which is mediated by RIPK1-induced oxidative stress upon caspase and necroptosis inhibition to further ensure induction of cell death.

Identifiers

PMID28592892
PMCPMC5462742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.